CLINIC-RANDOMIZED TRIAL OF CLINICAL DECISION SUPPORT FOR OPIOID USE DISORDERS IN MEDICAL SETTINGS (CTN-0095). DSC5 CONTRACT. 09/20/2019 - 06/28/2024. N01DA-19-2250.
CLINIC-RANDOMIZED TRIAL OF CLINICAL DECISION SUPPORT FOR OPIOID USE DISORDERS IN MEDICAL SETTINGS (CTN-0095). DSC5 CONTRACT. 09/20/2019 - 06/28/2024. N01DA-19-2250.
批准号:
10044314
负责人:
PAUL VANVELDHUISEN
金额:
$88.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-20 至 2024-06-28
关键词:
Alcohol or Other Drugs useAreaClinicClinical ResearchClinical TrialsCommon Data ElementDataData CollectionDevelopmentDrug abuseFamiliarityGoalsInformation SystemsLeadershipMedicalNational Institute of Drug AbuseOnline SystemsPhaseProtocols documentationQuality ControlRandomized Clinical TrialsReportingResearchResearch SupportRoleScienceServicesSiteStructureSubstance abuse problemSystemSystems IntegrationTestingUrsidae Familybaseclinical decision supportdata managementdesignexperienceflexibilityopioid use disorderstatistics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CLINIC-RANDOMIZED TRIAL OF CLINICAL DECISION SUPPORT FOR OPIOID USE DISORDERS IN MEDICAL SETTINGS (CTN-0095).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DSC MANAGEMENT AND SUPPORT FOR HELPING TO END ADDICTION LONG-TERM INITIATIVE (HEAL). 9/1/2021-8/31/2022. N01DA-19-2250. TASK ORDER 75N95021F00005 (TO2
-
批准号:10505740
-
项目类别:
-
资助金额:$243.29万
-
财政年份:2021
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
ADOLESCENT SCREENING TO HELP ELIMINATE MISUSE (CTN-0060-A-1). 8/1/2020 - 12/31/2021. N01DA-19-2250. TASK ORDER 75N95020F00003 (TO14).
-
批准号:10287993
-
项目类别:
-
资助金额:$18.51万
-
财政年份:2020
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
ADOLESCENT SCREENING TO HELP ELIMINATE MISUSE (CTN-0060-A-1). 8/1/2020 - 12/31/2021. N01DA-19-2250. TASK ORDER 75N95020F00003 (TO14).
-
批准号:10551005
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2020
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
DSC MANAGEMENT AND SUPPORT FOR HELPING TO END ADDICTION LONG-TERM INITIATIVE (HEAL). 9/21/2020-9/20/2021. N01DA-19-2250. TASK ORDER 75N95020F00008 (TO
-
批准号:10288073
-
项目类别:
-
资助金额:$110.42万
-
财政年份:2020
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). 03/01/2020 - 08/15/2022. N01DA-19-2250.T
-
批准号:10290928
-
项目类别:
-
资助金额:$177.2万
-
财政年份:2020
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
DSC MANAGEMENT AND SUPPORT FOR HELPING TO END ADDICTION LONG-TERM INITIATIVE (HEAL). 9/21/2020-9/20/2021. N01DA-19-2250. TASK ORDER 75N95020F00008 (TO
-
批准号:10455395
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2020
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
PEER INTERVENTION TO LINK OVERDOSE SURVIVORS TO TREATMENT (CTN-0107). 9/1/2020-7/3/2023. N01DA-19-2250. TASK ORDER 75N95020F00006 (TO17).
-
批准号:10288034
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2020
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
PRIMARY CARE OPIOID USE DISORDERS TREATMENT TRIAL (CTN-0074). 9/1/2020 - 12/31/2021. N01DA-19-2250. TASK ORDER 75N95020F00004 (TO15).
-
批准号:10288032
-
项目类别:
-
资助金额:$23.64万
-
财政年份:2020
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
TRANSCRANIAL MAGNETIC STIMULATION FOR THE TREATMENT OF METHAMPHETAMINE/COCAINE USE DISORDER (CTN-0108). 9/21/2020-7/17/2023. N01DA-19-2250. TASK ORDER
-
批准号:10288053
-
项目类别:
-
资助金额:$83.09万
-
财政年份:2020
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
INTEGRATING PHARMACY-BASED PREVENTION&TREATMENT OF OPIOID&OTHER SUBSTANCE USE DISORDERS: A SURVEY OF PHARMACISTS&STAKEHOLDERS. 9/1/2020-7/31/2022. N01
-
批准号:10288033
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2020
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). 03/01/2020 - 08/15/2022. N01DA-19-2250.T
-
批准号:10667369
-
项目类别:
-
资助金额:$135.06万
-
财政年份:2020
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
RURAL EXPANSION OF MEDICATIONS FOR OPIOID USE DISORDER (CTN-0102). DSC5 CONTRACT. 09/20/2019 - 05/15/2023. N01DA-19-2250.
-
批准号:10044330
-
项目类别:
-
资助金额:$161.41万
-
财政年份:2019
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER. 09/01/2019 - 02/29/2020. N01DA-19-2250. TASK ORDER NO 01.
-
批准号:10044303
-
项目类别:
-
资助金额:$95.79万
-
财政年份:2019
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
SUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL (CTN-0101). DSC5 CONTRACT. 09/20/2019 - 11/16/2020. N01DA-19-2250.
-
批准号:10703337
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2019
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
ANCILLARY STUDY OF THE ADOPTION AND SUSTAINABILITY OF ED-INITIATED BUPRENORPHINE (CTN-0079-A-1). DSC5 CONTRACT. 09/20/2019 - 02/28/2021. N01DA-19-2250.
-
批准号:10044312
-
项目类别:
-
资助金额:$55.25万
-
财政年份:2019
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
EMERGENCY DEPARTMENT-INITIATED BUPRENORPHINE AND VALIDATION NETWORK TRIAL (CTN-0099). DSC5 CONTRACT. 09/20/2019 - 11/12/2022. N01DA-19-2250.
-
批准号:10701629
-
项目类别:
-
资助金额:$49.03万
-
财政年份:2019
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
SUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL (CTN-0101). DSC5 CONTRACT. 09/20/2019 - 11/16/2020. N01DA-19-2250.
-
批准号:10251828
-
项目类别:
-
资助金额:$74.39万
-
财政年份:2019
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
EMERGENCY DEPARTMENT-INITIATED BUPRENORPHINE AND VALIDATION NETWORK TRIAL (CTN-0099). DSC5 CONTRACT. 09/20/2019 - 11/12/2022. N01DA-19-2250.
-
批准号:10044323
-
项目类别:
-
资助金额:$166.17万
-
财政年份:2019
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
ANCILLARY STUDY OF THE ADOPTION AND SUSTAINABILITY OF ED-INITIATED BUPRENORPHINE (CTN-0079-A-1). DSC5 CONTRACT. 09/20/2019 - 02/28/2021. N01DA-19-2250.
-
批准号:10265981
-
项目类别:
-
资助金额:$23.71万
-
财政年份:2019
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
CULTURALLY CENTERED TREATMENT FOR OUD IMPLEMENTATION FOR ADDICTION TREATMENT PROGRAMS SERVING AMERICAN INDIAN/ALASKA NATIVES (CTN-0096). DSC5 CONTRACT. 09/20/2019 - 11/15/2022. N01DA-19-2250.
-
批准号:10044316
-
项目类别:
-
资助金额:$51.2万
-
财政年份:2019
-
负责人:PAUL VANVELDHUISEN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: